Showing 3 of 3 recruiting trials for “Clear cell papillary renal cell carcinoma”
Palbociclib and Sasanlimab for the Treatment of Advanced Clear Cell Renal Cell Carcinoma (ccRCC) or Papillary Renal Cell Carcinoma (pRCC)
👨⚕️ Ramaprasad Srinivasan, M.D., National Cancer Institute (NCI)📍 1 site📅 Started Apr 2024View details ↗
Study of Orellanine in Metastatic Clear-Cell or Papillary Renal Cell Carcinoma
Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →